Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of age-related disparities in newly diagnosed myeloma finds inferior outcomes driven by increased frailty and advanced age, but also influenced by suboptimal treatment selection with PI–IMiD combinations looking best.”
Title: Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study
Authors: Xinhe Shan, Rowan Kuiper, Chuling Ding, Pashna N. Munshi, Edward A. Stadtmauer, Sandra P. Susanibar-Adaniya
You can read the Full Article in Haematologica.
More posts featuring Robert Orlowski.
